Atmos Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Gritti, the web3 social fitness app building healthier habits through engaged communities and superior gamification, is pleased to announce the...

Examines people’s eyes for signs of neurodegenerative diseases including Parkinson’s, Alzheimer’s and multiple sclerosis

Molecule.one grows its drug synthesis AI platform with a $4.6M seed round Polish computational chemistry outfit Molecule.one has raised $4.6M to expand its quest to bring theoretical drug molecules to reality. Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. theoretical treatments but can’t actually make the molecules. The company’s system enters play when you have some exotic new compound you want to make in order to test it in real life, but don’t know how to make it. After all, these ...

Polish computational chemistry outfit Molecule.one has raised $4.6M to expand its quest to bring theoretical drug molecules to reality. Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. Molecule.one went on stage at Disrupt SF 2019's Startup Battlefield, where they explained the difficulty faced by the drug discovery industry, basically that they come up with lots of theoretical treatments but can't actually make the molecules.